Home | About us | Editorial Board | Search | Ahead of print | Current Issue | Archives | Instructions | Online submissionContact Us   |  Subscribe   |  Advertise   |  Login  Page layout
Wide layoutNarrow layoutFull screen layout
Lung India Official publication of Indian Chest Society  
  Users Online: 1293   Home Print this page  Email this page Small font size Default font size Increase font size
Year : 1983  |  Volume : 1  |  Issue : 4  |  Page : 129-134

Hyperuricemia And Arthralgia During Pyrazinamide Therapy With Antituberculosis Regimens Containing Rifampicin Or Ethambutol

Correspondence Address:
T. N Sharma

Login to access the Email id

Source of Support: None, Conflict of Interest: None

Rights and PermissionsRights and Permissions

Weekly serum uric acid concentrations were estimated in 118 patients on various pyrazinamide (PZA) regimens and in 70 patients on non-pyrazinamide regimens. Hyperuricemia was encountered in 45 per cent at the end of first week, 72 percent by end of second week, and 79 per cent by end of fourth week in patients taking pyrazinamide and in none of the patients on non-pyrazinamide regimens except two on streptomycin, isoniazid and ethambutol (SHE) regimen. There was a continuous rise in serum uric acid levels throughout the four weeks observation period; however, the maximum increase was observed during first week. Though statistically highly significant (P<0.001), elevations in uric acid levels caused by ethambutol were of smaller magnitude as compared to pyrazinamide, it only marginally raised the a low incidence being observed in those on rifampicin containing regimens.

Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded156    
    Comments [Add]    

Recommend this journal